The association between LOC126862571 (BRD4-Independent Group 4 Enhancer GRCh37_chr17:41243136-41244335) and Ovarian Cancer is well established and manually curated, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants737
Symptoms8
Compounds0
Trials0
Publications170
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.